In order to curb misuse of pharmaceutical trade mark
registrations, the Angolan trade marks office (IAPI) has issued
notice 9/2022 which states that, going forward, all registration
certificates for pharmaceutical trade marks in class 5 shall now
contain the following disclaimer:
“This title grants the right of ownership and
exclusive use of the trademark throughout the national territory,
excluding the certification of the pharmaceutical product
(registration and authorization for the introduction of the drug in
the Angolan market), which is the attribution of the Department of
the competent Ministry”
The requirement took effect for 29 July 2022.
The IAPI is taking this preventive measure in order to clarify
that trade mark registration does not necessarily mean that a
proprietor has obtained the necessary authority to launch a
particular pharmaceutical product in Angola.